MX2014012285A - Composicion farmaceutica que contiene un inhibidor de serina proteasa para tratar o prevenir infeccion por el virus de la influenza. - Google Patents
Composicion farmaceutica que contiene un inhibidor de serina proteasa para tratar o prevenir infeccion por el virus de la influenza.Info
- Publication number
- MX2014012285A MX2014012285A MX2014012285A MX2014012285A MX2014012285A MX 2014012285 A MX2014012285 A MX 2014012285A MX 2014012285 A MX2014012285 A MX 2014012285A MX 2014012285 A MX2014012285 A MX 2014012285A MX 2014012285 A MX2014012285 A MX 2014012285A
- Authority
- MX
- Mexico
- Prior art keywords
- methods
- treating
- inhibitor
- virus infection
- influenza virus
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 3
- 241000712461 unidentified influenza virus Species 0.000 title abstract 2
- 230000009385 viral infection Effects 0.000 title abstract 2
- 229940122055 Serine protease inhibitor Drugs 0.000 title 1
- 101710102218 Serine protease inhibitor Proteins 0.000 title 1
- 239000003001 serine protease inhibitor Substances 0.000 title 1
- 239000003112 inhibitor Substances 0.000 abstract 4
- 101710154606 Hemagglutinin Proteins 0.000 abstract 2
- 101710093908 Outer capsid protein VP4 Proteins 0.000 abstract 2
- 101710135467 Outer capsid protein sigma-1 Proteins 0.000 abstract 2
- 101710176177 Protein A56 Proteins 0.000 abstract 2
- 239000000185 hemagglutinin Substances 0.000 abstract 2
- 108091005804 Peptidases Proteins 0.000 abstract 1
- 239000004365 Protease Substances 0.000 abstract 1
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 abstract 1
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 abstract 1
- 102000012479 Serine Proteases Human genes 0.000 abstract 1
- 108010022999 Serine Proteases Proteins 0.000 abstract 1
- 239000000427 antigen Substances 0.000 abstract 1
- 102000036639 antigens Human genes 0.000 abstract 1
- 108091007433 antigens Proteins 0.000 abstract 1
- 239000012634 fragment Substances 0.000 abstract 1
- 206010022000 influenza Diseases 0.000 abstract 1
- 230000002401 inhibitory effect Effects 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 230000006337 proteolytic cleavage Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
- A61K39/39533—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals
- A61K39/3955—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals against proteinaceous materials, e.g. enzymes, hormones, lymphokines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/145—Orthomyxoviridae, e.g. influenza virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
- A61K39/42—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum viral
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/40—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Virology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Pulmonology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Endocrinology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261624519P | 2012-04-16 | 2012-04-16 | |
| US201361759469P | 2013-02-01 | 2013-02-01 | |
| PCT/US2013/036522 WO2013158516A1 (en) | 2012-04-16 | 2013-04-15 | Methods for treating or preventing influenza virus infection by administering a serine protease inhibitor |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2014012285A true MX2014012285A (es) | 2015-04-13 |
Family
ID=48184523
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2014012285A MX2014012285A (es) | 2012-04-16 | 2013-04-15 | Composicion farmaceutica que contiene un inhibidor de serina proteasa para tratar o prevenir infeccion por el virus de la influenza. |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US9498529B2 (enExample) |
| EP (2) | EP2838558A1 (enExample) |
| JP (2) | JP6446355B2 (enExample) |
| KR (1) | KR20150008383A (enExample) |
| CN (1) | CN104244978A (enExample) |
| AU (2) | AU2013249577A1 (enExample) |
| BR (1) | BR112014025339A8 (enExample) |
| CA (2) | CA2869010A1 (enExample) |
| HK (1) | HK1202817A1 (enExample) |
| MX (1) | MX2014012285A (enExample) |
| NZ (1) | NZ631105A (enExample) |
| SG (1) | SG11201405163RA (enExample) |
| WO (1) | WO2013158516A1 (enExample) |
| ZA (1) | ZA201406194B (enExample) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2017228293B2 (en) * | 2016-02-29 | 2023-05-25 | Regeneron Pharmaceuticals, Inc. | Rodents having a humanized Tmprss gene |
| KR101693243B1 (ko) * | 2016-06-15 | 2017-01-05 | 재단법인 한국파스퇴르연구소 | 인플루엔자 바이러스의 복제에 관여하는 신규 인간 유전자 및 이의 용도 |
| LT3638698T (lt) * | 2018-01-26 | 2021-04-12 | Regeneron Pharmaceuticals, Inc. | Antikūnai prieš tmprss2 ir antigeną surišantys fragmentai |
| CN115427457A (zh) | 2020-02-10 | 2022-12-02 | 瑞泽恩制药公司 | 抗tmprss2抗体和抗原结合片段 |
| WO2021190980A1 (en) | 2020-03-22 | 2021-09-30 | Quadrucept Bio Limited | Multimers for viral strain evolution |
| WO2021195119A1 (en) * | 2020-03-24 | 2021-09-30 | Corcept Therapeutics Incorporated | Methods of reducing the risk of, severity of, and treating coronavirus infections |
| EP3964207A1 (en) | 2020-09-02 | 2022-03-09 | Christian-Albrechts-Universität zu Kiel | Antiviral pharmaceutical composition for topical administration |
| WO2022184659A1 (en) | 2021-03-01 | 2022-09-09 | Quadrucept Bio Limited | Antibody domains & multimers |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6166194A (en) * | 1998-06-29 | 2000-12-26 | Myriad Genetics, Inc. | TMPRSS2 is a tumor suppressor |
| WO2004097358A2 (en) | 2003-05-02 | 2004-11-11 | Bayer Healthcare Ag | Diagnostics and therapeutics for diseases associated with human transmembrane serine protease 2 (tmprss2) |
| KR101387781B1 (ko) * | 2005-01-07 | 2014-04-21 | 렉시컨 파마슈티컬스 인코퍼레이티드 | 앤지오포이에틴-유사 단백질 4 (ａｎｇｐｔｌ４) 에 대한단일클론 항체 |
| US20070191322A1 (en) | 2006-02-01 | 2007-08-16 | Savage Paul B | Cationic Steroid Microbial Compositions and Methods of Use |
| JP2008247864A (ja) * | 2007-03-30 | 2008-10-16 | Univ Of Tokushima | モザイクセリンプロテアーゼ、ｍｓｐとその用途 |
| JP2008308438A (ja) * | 2007-06-14 | 2008-12-25 | Mitsubishi Tanabe Pharma Corp | 新規なインフルエンザ治療および／または予防薬 |
| BRPI1014745B1 (pt) | 2009-06-22 | 2020-10-20 | Borealis Ag | artigo para interior de automóveis com odor reduzido |
| DK3702374T3 (da) * | 2012-02-15 | 2022-06-27 | Cydex Pharmaceuticals Inc | Fremsgangsmåde til fremstilling for cyclodextrin-derivater |
-
2013
- 2013-04-15 SG SG11201405163RA patent/SG11201405163RA/en unknown
- 2013-04-15 KR KR1020147028956A patent/KR20150008383A/ko not_active Ceased
- 2013-04-15 MX MX2014012285A patent/MX2014012285A/es active IP Right Grant
- 2013-04-15 BR BR112014025339A patent/BR112014025339A8/pt not_active Application Discontinuation
- 2013-04-15 CN CN201380020133.9A patent/CN104244978A/zh active Pending
- 2013-04-15 AU AU2013249577A patent/AU2013249577A1/en not_active Abandoned
- 2013-04-15 EP EP13718744.9A patent/EP2838558A1/en not_active Ceased
- 2013-04-15 CA CA2869010A patent/CA2869010A1/en not_active Withdrawn
- 2013-04-15 EP EP19155349.4A patent/EP3536342A1/en not_active Withdrawn
- 2013-04-15 CA CA3219083A patent/CA3219083A1/en active Pending
- 2013-04-15 US US13/862,497 patent/US9498529B2/en active Active
- 2013-04-15 HK HK15103529.7A patent/HK1202817A1/xx unknown
- 2013-04-15 NZ NZ631105A patent/NZ631105A/en unknown
- 2013-04-15 JP JP2015507076A patent/JP6446355B2/ja active Active
- 2013-04-15 WO PCT/US2013/036522 patent/WO2013158516A1/en not_active Ceased
-
2014
- 2014-08-22 ZA ZA2014/06194A patent/ZA201406194B/en unknown
-
2017
- 2017-10-20 JP JP2017203146A patent/JP2018048169A/ja not_active Withdrawn
-
2018
- 2018-01-12 AU AU2018200265A patent/AU2018200265B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| AU2018200265B2 (en) | 2019-07-18 |
| HK1202817A1 (en) | 2015-10-09 |
| ZA201406194B (en) | 2016-08-31 |
| CN104244978A (zh) | 2014-12-24 |
| CA2869010A1 (en) | 2013-10-24 |
| AU2018200265A1 (en) | 2018-02-01 |
| CA3219083A1 (en) | 2013-10-24 |
| JP6446355B2 (ja) | 2018-12-26 |
| NZ631105A (en) | 2016-09-30 |
| EP3536342A1 (en) | 2019-09-11 |
| US9498529B2 (en) | 2016-11-22 |
| KR20150008383A (ko) | 2015-01-22 |
| AU2013249577A1 (en) | 2014-10-02 |
| EP2838558A1 (en) | 2015-02-25 |
| US20130273070A1 (en) | 2013-10-17 |
| JP2015516975A (ja) | 2015-06-18 |
| WO2013158516A1 (en) | 2013-10-24 |
| BR112014025339A2 (pt) | 2013-10-24 |
| BR112014025339A8 (pt) | 2018-01-16 |
| SG11201405163RA (en) | 2014-09-26 |
| JP2018048169A (ja) | 2018-03-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2014012285A (es) | Composicion farmaceutica que contiene un inhibidor de serina proteasa para tratar o prevenir infeccion por el virus de la influenza. | |
| MX387277B (es) | Composiciones basadas en anticuerpos neutralizantes suministrados intranasalmente para eficacia terapéutica aumentada. | |
| EA201791086A1 (ru) | Человеческие антитела против гемагглютинина вируса гриппа | |
| EA201201321A1 (ru) | Соединения (липопептиды на основе цистеина) и композиции в качестве агонистов tlr2, применяемые для лечения инфекционных, воспалительных, респираторных и других заболеваний | |
| BR112012019042A2 (pt) | "inibidores de serina protease tipo tripsina, e sua preparação e uso". | |
| CL2013003145A1 (es) | Formulación farmacéutica que comprende mezcla de anticuerpo anti-alfa4beta7, un antioxidante o quelante y al menos un aminoácido libre. | |
| IN2014CN03113A (enExample) | ||
| UA116999C2 (uk) | Виділене антитіло до гемаглютиніну та фармацевтична композиція, що його містить | |
| CO6660439A2 (es) | Eliminación de serina proteasa por tratamiento con dióxido de silicona finamente dividido | |
| AU2014310935B2 (en) | Combination vaccine | |
| EA201692467A1 (ru) | Вакцины против вируса гриппа и их применения | |
| EA033386B1 (ru) | Рекомбинантные иммуногенные полипептиды стеблевого домена гемагглютинина вируса гриппа а и их применение | |
| BR112015021999A2 (pt) | inibidores de indoleamina 2,3-dioxigenase (ido) | |
| PE20170290A1 (es) | Vacunas contra virus de influenza y usos de las mismas | |
| EA201591164A1 (ru) | Вакцины против вируса гриппа и их применение | |
| EA201391515A1 (ru) | Инактивированная вакцина вируса денге | |
| CU24580B1 (es) | Vectores atenuados de influenza para la prevención y/o tratamiento de enfermedades infecciosas y para el tratamiento de enfermedades oncológicas | |
| EA201290897A1 (ru) | Вакцины для пандемического гриппа | |
| EP3939604A3 (en) | Influenza hemagglutinin protein vaccines | |
| EA201290792A1 (ru) | Пептиды для вакцины против аллергии на березу | |
| EA201400235A1 (ru) | Вакцины против гриппа на основе н5 | |
| EA201590460A1 (ru) | Способ и средство для лечения и профилактики заболеваний, вызываемых (+)рнк-содержащими вирусами | |
| EA201590678A1 (ru) | Соединения для лечения блокады ремиелинизации при заболеваниях, связанных с экспрессией белка оболочки herv-w | |
| EA201690966A1 (ru) | Новое соединение для лечения тяжелой гипогликемии | |
| EP4477231A3 (en) | Combination vaccine |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant or registration |